Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Newton-Wellesley Hospital said five staff members who had worked on its fifth floor were diagnosed with brain tumors — none ...

More than half a decade after the pandemic began, key information on COVID-19's origins continues to dribble out of the U.S.

The students and their families came from 20 different high schools in McLean and Woodford counties for the 26th annual ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, ...

Scientific and Medical Equipment House Co. (Equipment House) announced today that it has received approval to award a tender ...

Peer-reviewed journals rejected their followup study on the 2023-2024 formulation of mRNA vaccines against the JN.1 variant ...

Osaka Medical and Pharmaceutical University. "All pathogen proteins, like the SARS-CoV-2 spike, have invariant structures critical for their functions, making them good targets for mutation ...

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...